Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002001
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
The Antiviral Efficacy of Concurrent Zidovudine and 23-Dideoxyinosine or 23-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease
Sponsor:
Glaxo Wellcome
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
The Antiviral Efficacy of Concurrent Zidovudine and 23-Dideoxyinosine or 23-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease
Status:
COMPLETED
Status Verified Date:
1991-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the virologic effect of combined administration of zidovudine and ddI or ddC To evaluate the immunologic effects of zidovudine and ddI or ddC To evaluate combined administration of zidovudine and ddI or ddC for clinical efficacy To evaluate the safety and the tolerance of the coadministration of zidovudine and ddI or ddC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 02 | None | None | None |